{"id":"NCT02706483","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Long Term Safety Study of Plecanatide","officialTitle":"An Open Label, Long Term Safety and Tolerability Study of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01","primaryCompletion":"2017-05","completion":"2017-06","firstPosted":"2016-03-11","resultsPosted":"2020-08-18","lastUpdate":"2020-08-18"},"enrollment":2272,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Irritable Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Plecanatide","otherNames":[]}],"arms":[{"label":"Plecanatide","type":"EXPERIMENTAL"}],"summary":"Multi-center, open-label, long-term safety study","primaryOutcome":{"measure":"Number of Participants With Treatment Related Adverse Events.","timeFrame":"up to 53 weeks","effectByArm":[{"arm":"Plecanatide","deltaMin":205,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":204,"countries":["United States"]},"refs":{"pmids":["30277094"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":45,"n":2272},"commonTop":["Diarrhoea","Upper Respiratory Tract Infection","Urinary Tract Infection","Nasopharyngitis","Nausea"]}}